Hsiao D Lieu's Net Worth
$325 Thousand
Who is Hsiao D Lieu?
Hsiao D Lieu does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, and Nile Therapeutics, Inc..
SEC CIK
Hsiao D Lieu's CIK is 0001468482
Past Insider Trading and Trends
2023 was Hsiao D Lieu's most active year for acquiring shares with 7 total transactions. Hsiao D Lieu's most active month to acquire stocks was the month of February. 2021 was Hsiao D Lieu's most active year for disposing of shares, totalling 5 transactions. Hsiao D Lieu's most active month to dispose stocks was the month of October. 2021 saw Hsiao D Lieu paying a total of $120,600.00 for 110,000 shares, this is the most they've acquired in one year. In 2021 Hsiao D Lieu cashed out on 22,258 shares for a total of $283,934.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.42
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -19.35K |
—
|
—
|
0
|
Apr 5
| |||
Form 4
| -9.10% | -5.43K |
$1.34 | -$7,276.20 | 54.25K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
| +2,034.55% | 53K |
—
|
—
| 55.6K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
$17.03 | -$19,880.00 |
0
|
Scheduled
|
Oct 5
| ||
Form 4
| -100.00% | -2.26K |
$17.73 | -$143,454.00 |
0
|
Aug 11 - Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| -89.56% | -1.56K |
$22.00 | -$34,364.00 | 182 |
May 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nile Therapeutics, Inc. (CAPR) Snapshot price: $3.9
Executive VP, Clinical Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12,500.00% | 12.5K |
—
|
—
| 12.6K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
∞
| 100 |
$4.60 | $460.00 | 100 |
Mar 10 - Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||